CD4+/CD8+ ratio in atopic dogs before and after treatment with cidosporin A: Preliminary results;Valutazione del rapporto CD4+/CD8+ nei cani affetti da dermatite atopica prima e dopo terapia con cidosporina A: Risultati preliminari

Veterinaria

Volumn 26, Issue 3, 2012, Pages 31-37

  Cornegliani, Luisa ^a   Comazzi, Stefano ^b   Beccati, Massimo ^c   Martini, Valeria ^b   Vercelli, Antonella ^a  

^a Ambulatorio Veterinario Associato   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Medico Veterinario   (Italy)

Author keywords

Canine atopic dermatitis; Cidosporin

Indexed keywords

CANIS FAMILIARIS;

EID: 84875945720     PISSN: 03943151     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Robson D: Review of the properties and mechanisms of action of cy-dosporine with an emphasis on dermatological therapy in dogs, cats and people.The Veterinary Records 152:768-772,2003.
2. Fellman CL, Stokes JV, Archer TN, et al. Cyclosporine A affects the in vitro expression ofT cell activation-related molecules and cytokines in dogs.Vet Immunol Immunopathol 140: 175-180,2011.
3. Rao A, Luo C, Hogan PG:Transcription factors of the NFAT family: regulation and function. Annual Rev. Immunol 15:707-747, 1997.
4. KobayashiT, MomoiY, IwasakiT: Cyclosporine A inhibits the m RNA expression of IL-2, IL-4 and TNF-y, but notTNF-a in canine mononuclear cells. J Vet Med Sci 69 (9): 887-892,2007.
5. Maeda S.Tsuchida H, Shibata S, et al.: Expression analysis of CCL27 and CCL28 mRNA in lesional and non-lesional skin of dogs with atopic dermatitis. J Vet Med Sci 70 (I): 51-55,2008.
6. Tizard IR: Helper T cells and their response to antigen. In: Veterinary Immunology: and introduction Tizard IR ed.WB Saunders Philadelphia. 2000:98-109.
7. Farrell AM, Antrobus P, Simpson D, et al.: A rapid flow cytometric assay to detect CD4I and CD8I T-helper (Th) 0,Thl andTh2 cells in whole blood and its application to study cytokine levels in atopic dermatitis before and after cyclosporin therapy. British J Dermatol 144:24-33,2001.
8. Lee SY, Shim JY, Kim JH, et al.: Cyclosporine treatment decrease the percentage of cutaneous lymphocyte antigen (CLA)+ CD4+ T cells in children with severe atopic dermatitis. Allergy Net 59: 1129-1130, 2004.
9. Hij'nen DJ, Haeck L, Van Kraats AA, et al.: Cyclosporin A reduces CD41+CD25+ regulatoryT-cell numbers in patients with atopic dermatitis J Allergy Clin Immunol 124 (4): 856-858,2009.
10. Brandt C, PavlovicV, RadbruchA, et al.: Low-dose cyclosporine A therapy increases the regulatory T cell population in patients with atopic dermatitis. Allergy 64: 1588-1596,2009.
11. Morris DO, Clayton DJ, Drobatz KJ, et al.: Response to Malassezia pachydermatis by peripheral blood mononuclear cells from clinically normal and atopic dogs. Am J Vet Res 63: 358-62,2002.
12. Comazzi S, Gelain ME, Spagnolo V, et al.: Flow cytometric patterns in blood from dogs with non-neoplastic and neoplastic hematologic diseases using double labeling for CD 18 and CD45.Vet Clin Pathol 35 (I): 47-54,2006.
13. Izci C, Celik I, Alkan F, et al.: Histologic characteristics and local cellular immunity of the gland of the third eyelid after topical opthalmic administration of 2% cyclosporine for treatment of dogs with kera-toconjuntivitis sicca. Am J Vet Res 63 (5): 668-694,2002.
14. Gilber BC, Andrews J,Wilkie DA, et al.: Cellular immunity in dogs with keratoconjunctivitis sicca before and after treatment with topical 2% cyclosporine.Vet Immunol Immunopathol 49 (3): 199-208, 1995.
15. OlivryT: International Task Force of Canine Dermatitis. New diagnostic criteria for canine atopic dermatitis.Vet Dermatol 21 (I): 123-126,2010.
16. Olivry T, Marsella R, Iwasaki T, et al.:Validation of CADESI-03, a severity scale for clinical trials enrolling dogs with atopic dermatitis. Vet Dermatol 18:78-86,2007.
17. Prelaud P, Power HT: Dermatite atopica canina. In Guaguere E. & Prelaud P. Guida pratica di dermatologia canina. Kalianxis Merial; 233-258,2006.
18. OlivryT, Marsella R, Iwasaki T, Mueller R: International Task Force On Canine Atopic Dermatitis.Validation of CADESI-03, a severity scale for clinical trials enrolling dogs with atopic dermatitis.Vet Dermatol 18 (2): 78-86,2007.
19. OlivryT, Mueller R, NuttallT.et al.: International Task Force on Canine Atopic Dermatitis. Determination of CADESI-03 thresholds for increasing severity levels of canine atopic dermatitis.Vet Dermatol 19 (3): 115-119,2008.
20. Hill PB, Lau P, Rydnicek J: Development of an owner-assessed scale to measure the severity of pruritus in dogs.Vet Dermatol 18 (5): 301 -308,2007.
21. Gelain ME, Mazzilli M, Riondato F, et al.: Aberrant phenotypes and quantitative antigen expression in different subtypes of canine lymphoma by flow cytometry Vet Immunol Immunopathol 121 (3-4): 179-188,2007.
22. Halliwell R: Revised nomenclature for veterinary allergy.Vet Immunol Immunopathol 114:2007-8,2006.
23. Favrot C, Steffan J, Seewald W, et al.: A prospective study on the clinical features of chronic canine atopic dermatitis and its diagnosis. Vet Dermatol 21 (I): 23-31,2010.
24. Halliwell REW:The immunopathogenesis of allergic skin diseases of dog and cat EJACP. 213-218,2009.
25. Hensel P: Nutrition and skin diseases in veterinary medicine. Clin Dermatol 28(6): 686-93,2010.
26. Marsella R: Canine Atopic Dermatitis: What's New? Compend Con-tin Educ Vet 32(2): EI -4,2010.
27. Jaeger K, Linek M, Power HT, et al.: Breed and site predispositions of dogs with atopic dermatitis: a comparison of five locations in three continents.Vet Dermatol 21(1): 118-122,2010.
28. Meury S, MolitorV, Doherr MG, et al.: Role of the environment in the development of canine atopic dermatitis in Labrador and golden retrievers. Vet Dermatol 22 (4): 327-334,2011.
29. Wilhem S, Kovalik M, Favrot C: Breed-associated phenotypes in canine atopic dermatitis.Vet Dermatol 22 (2): 143-149,2010.
30. McEwan NA, Mellor D, Kalna G: Adherence by Staphylococcus interme-dius to canine comeocytes: a preliminary study comparing noninflamed and inflamed atopic canine skin. Vet Dermatol 17 (2): 151-154,2006.
31. OlivryT, DeBoer DJ, Favrot C, et al.Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis.Vet Dermatol 21 (3): 233-248,2010.
32. Scott DW, Miller WH, Griffin GE: Skin immune system and allergic diseases. In Muller & Kirk's Small Animal Dermatology. W.B. Saunders Company, Philadelphia, 2001,543-666.
33. Marsella R, Samuelson D: Unravelling the skin barrier: a new paradigm for atopic dermatitis and house dust mites.Vet Dermatol 20 (5-6): 533-540,2009.
34. Shimada K,Yoon JS.Yoshihara T, et al.: Increased Transepidermal water loss and decreased ceramide content in lesional and non-lesional skin of dogs with atopic dermatitis.Vet Dermatol 20 (5-6): 541 -546,2009.
35. Weiss DJ: Application of flow cytometric techniques to veterinary clinical hematology.Vet Clin Pathol 31 (2): 72-82,2002.
36. Baumgrass R, Brandt C.Wegner F, et al.: Low-dose, but not high-do-se, cyclosporin A promotes regulatory T-cell induction, expansion, or both.J Allergy Clin Immunol 126 (I): 183-184,2010.
37. Breathnach RM, Baker KP, Quinn PJ, et al.: Clinical, immunological and histopathological findings in a subpopulation of dogs with pododer-matitis.Vet Dermatol 16 (6): 364-72,2005.
38. Caswell JF, Yager JA, Parker JP, et al.: A prospective study of the im-munophenotype and temporal changes in the histological lesions of canine demodicosis.Vet Pathol 34:279-87, 1997.
39. Denerolle P, Bourdoiseau G, Magnol JP, et al.: German shepherd deep pyoderma: a prospective study of 23 cases. Vet Dermatol 9:242-248, 1998.